DIAGNOSTIC PERFORMANCE OF FIVE IMMUNOLOGICAL RAPID KITS IN COMPARISON WITH POLYMERASE CHAIN REACTION FOR SARS-COV-2 ANTIBODIES
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Department of Microbiology, Nasarawa State University Keffi
DOI
Abstract
While molecular techniques remain the gold standard for diagnosis of acute SARS-CoV-2
infection, serological tests have the unique potential to ascertain how much of the population
has been exposed to the COVTD-19 pathogen. There have been limited published studies to
date documenting the performance of SARS-CoV-2 antibody assays in Nigeria and so we
evaluated the diagnostic performance of five (5) immunoassay on a set of clinical samples.
Five automated immunoassays (2019-nCoV IgG/IgM antibody determination kit, Tigsun
COVID-19 combo IgM/IgG rapid test, rapid response COV1D-19 IgG/IgM test, COVTD-19
IgM-IgG combined antibody rapid test, iChroma COVID-19 Ab) were tested. Three hundred
and fourteen specimens were analyzed from health care workers who tested positive by
polymerase chain reaction for SARS-CoV-2 with symptoms consistent with SARS-CoV-2
receiving treatment at two treatment centres inNasarawa State from March to September, 2020
with control of 134 health care workers who tested negative PCR for SARS-CoV-2 with no
symptoms to SARS-CoV-2. The SARS-CoV-2 IgG/IgM antibody evaluated kits had a
sensitivity of 33% (2019-nCoV IgG/IgM antibody determination kit), 22% (Tigsun COVID-
19 combo IgM/IgG rapid test), 43% (rapid response COVID-19 IgG/IgM test), 44% (COVID-
19 IgM-IgG combined antibody rapid test), 25% (iChroma COVID-19 Ab), 100% sensitivity,
accuracy of 68.5% and Kappa coefficient of 0.7 and rapid response COVID-19 IgG/IgM test
cassette had a sensitivity of 33%, specificity of 100% and accuracy of 72.5% with Kappa
coefficient 0.7. The Tigsun COVID-19 combo IgM/IgG rapid test (lateral flow), positive,
COVID19 IgM-IgG combined antibody rapid test and iChroma COVID-19 Ab RT all had
sensitivity of zero percent. Serology was complementary to RT-PCR for the diagnosis of
COVID-19 at least 14 days after onset of symptoms. The assay panel needs to be improved to
serve as an option for the diagnosis of SARS-CoV-2 in resource constrained settings where
there are limited molecular diagnostics testing panels.
Description
Keywords
Citation
Anzaku, S.O. (2023) DIAGNOSTIC PERFORMANCE OF FIVE IMMUNOLOGICAL RAPID KITS IN COMPARISON WITH POLYMERASE CHAIN REACTION FOR SARS-COV-2 ANTIBODIES
